What to do if a patient experiences bradycardia and lip swelling after taking Ketorolac (ketorolac tromethamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bradycardia and Lip Swelling After Ketorolac Administration

Immediately stop ketorolac and treat this as a potential anaphylactic reaction requiring prompt intervention with epinephrine and supportive care.

Initial Assessment and Management

  1. Stop ketorolac administration immediately and maintain IV access 1
  2. Assess ABCs (Airway, Breathing, Circulation) and level of consciousness 1
  3. Position the patient appropriately:
    • If hypotensive: Trendelenburg position
    • If respiratory distress: Sitting up
    • If unconscious: Recovery position 1

Treatment Algorithm

For Bradycardia:

  1. Administer atropine 600 μg IV (0.6 mg) for bradycardia 1
  2. If patient is on beta-blockers: Consider glucagon 1-5 mg IV over 5 minutes, followed by infusion (5-15 μg/min) titrated to clinical response 1
  3. Monitor vital signs every 15 minutes until symptoms resolve 1

For Lip Swelling (Angioedema/Anaphylaxis):

  1. Administer epinephrine 0.01 mg/kg (1mg/mL dilution, maximum 0.5 mL) intramuscularly into lateral thigh if criteria for anaphylaxis are met 1
    • Can repeat every 5-15 minutes if needed
  2. Administer antihistamines:
    • Diphenhydramine 1-2 mg/kg or 25-50 mg IV slowly
    • Ranitidine 50 mg diluted in 5% dextrose to 20 mL total volume, injected IV over 5 minutes 1
  3. Administer corticosteroids: Equivalent to 1-2 mg/kg of methylprednisolone every 6 hours 1
  4. Fluid resuscitation if hypotensive: Rapid infusion of 1-2 liters normal saline at 5-10 mL/kg in first 5 minutes 1

Monitoring and Follow-up

  1. Observe for at least 24 hours after a severe reaction 1
  2. Document the reaction thoroughly including pre-infusion assessments, description and grading of the reaction, and management 1
  3. Prescribe an epinephrine auto-injector and educate patient on its use before discharge
  4. Refer to allergist for evaluation of NSAID allergy

Important Considerations

  • Ketorolac can cause serious hypersensitivity reactions including anaphylaxis, which may present with bradycardia and angioedema 2, 3
  • Bradycardia occurs in approximately 10% of patients with allergic anaphylaxis during anesthesia 1
  • Lip swelling (angioedema) is a concerning sign of potential anaphylaxis 1
  • Patients with asthma are at higher risk for severe reactions to NSAIDs including ketorolac 4
  • The combination of bradycardia and lip swelling strongly suggests an anaphylactoid/anaphylactic reaction rather than an isolated side effect 3, 5

Prevention of Future Episodes

  • Document ketorolac allergy prominently in medical records
  • Avoid all NSAIDs until allergist evaluation, as cross-reactivity may occur
  • Consider alternative analgesics from different drug classes (acetaminophen, tramadol, etc.)
  • Provide patient education about NSAID allergy and symptoms requiring immediate medical attention

Pitfalls to Avoid

  • Do not re-challenge with ketorolac or other NSAIDs before allergist evaluation
  • Do not delay epinephrine administration if anaphylaxis is suspected
  • Do not attribute bradycardia to other causes without considering anaphylaxis in this context
  • Do not discharge patient prematurely - observe for at least 24 hours after severe reactions
  • Do not forget to document the reaction for future reference

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ketorolac-induced anaphylaxis following oral administration: a case series.

Annals of medicine and surgery (2012), 2023

Research

Fatal adverse reaction to ketorolac tromethamine in asthmatic patient.

The American journal of forensic medicine and pathology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.